China Bio-immunity Corporation (HBB) Reports Q3 EPS of $0.31

China Bio-immunity Corporation (NYSE: HBB) reported Q3 EPS of $0.31, versus $0.64 reported last year. Revenue for the quarter came in at $181.71 thousand, versus $188.39 million reported last year.

For earnings history and earnings-related data on China Bio-immunity Corporation (HBB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c